Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Jenna Burton to Animals

This is a "connection" page, showing publications Jenna Burton has written about Animals.

 
Connection Strength
 
 
 
0.529
 
  1. Burton JH, Vail DM, Willcox JL, Al-Nadaf S, Adrianowycz S, Biggs D, Hayim R, Magee K, McMahon R, Mok I, Picone AM, Ralston J, Smith BM, Uyehara R, Willis AL, Johnston SA, Thamm DH. Low prevalence of occult cancer diagnosis when screening healthy, higher-risk, middle-aged to older dogs. J Am Vet Med Assoc. 2025 04 01; 263(4):492-498.
    View in: PubMed
    Score: 0.044
  2. Burton JH, Johnston SA, Vail DM, Eickhoff JC, Sykes KF, Brown JR, Shen L, Gervassi A, Page RL, Willcox JL, Al-Nadaf S, Willis AL, Biggs D, Ralston J, Mok I, Kurzman ID, Huelsmeyer MK, Hayim R, Smith BM, Thamm DH. Design of a randomized, placebo-controlled study evaluating efficacy and safety of a cancer preventative vaccine in dogs. Vet Immunol Immunopathol. 2024 Jan; 267:110691.
    View in: PubMed
    Score: 0.041
  3. Al-Nadaf S, Wittenburg LA, Skorupski KA, Burton JH. Population pharmacokinetics identifies rapid gastrointestinal absorption and plasma clearance of oral chlorambucil administered to cats with indolent lymphoproliferative malignancies. Am J Vet Res. 2022 Sep 29; 83(11):1-9.
    View in: PubMed
    Score: 0.038
  4. Culp WTN, Johnson EG, Giuffrida MA, Palm CA, Mayhew PD, Kent MS, Rebhun RB, Burton JH. Use of transrectal ultrasonography for assessment of the size and location of prostatic carcinoma in dogs. Am J Vet Res. 2019 Nov; 80(11):1012-1019.
    View in: PubMed
    Score: 0.031
  5. Al-Nadaf S, Rebhun RB, Curran KM, Venable RO, Skorupski KA, Willcox JL, Burton JH. Retrospective analysis of doxorubicin and prednisone as first-line therapy for canine B-cell lymphoma. BMC Vet Res. 2018 Nov 20; 14(1):356.
    View in: PubMed
    Score: 0.029
  6. Burton JH, Mazcko C, LeBlanc A, Covey JM, Ji J, Kinders RJ, Parchment RE, Khanna C, Paoloni M, Lana S, Weishaar K, London C, Kisseberth W, Krick E, Vail D, Childress M, Bryan JN, Barber L, Ehrhart EJ, Kent M, Fan T, Kow K, Northup N, Wilson-Robles H, Tomaszewski J, Holleran JL, Muzzio M, Eiseman J, Beumer JH, Doroshow JH, Pommier Y. NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma. Clin Cancer Res. 2018 12 01; 24(23):5830-5840.
    View in: PubMed
    Score: 0.028
  7. Gemignani F, Mayhew PD, Giuffrida MA, Palaigos J, Runge JJ, Holt DE, Robertson NA, Seguin B, Walker M, Singh A, Liptak JM, Romanelli G, Martano M, Boston SE, Lux C, Busetto R, Culp WTN, Skorupski KA, Burton JH. Association of surgical approach with complication rate, progression-free survival time, and disease-specific survival time in cats with mammary adenocarcinoma: 107 cases (1991-2014). J Am Vet Med Assoc. 2018 Jun 01; 252(11):1393-1402.
    View in: PubMed
    Score: 0.028
  8. Burton JH, Venable RO, Vail DM, Williams LE, Clifford CA, Axiak-Bechtel SM, Avery AC, Thamm DH. Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs. J Vet Intern Med. 2015 Jul-Aug; 29(4):1098-104.
    View in: PubMed
    Score: 0.023
  9. Burton J, Khanna C. The role of clinical trials in veterinary oncology. Vet Clin North Am Small Anim Pract. 2014 Sep; 44(5):977-87.
    View in: PubMed
    Score: 0.022
  10. Burton JH, Powers BE, Biller BJ. Clinical outcome in 20 cases of lingual hemangiosarcoma in dogs: 1996-2011. Vet Comp Oncol. 2014 Sep; 12(3):198-204.
    View in: PubMed
    Score: 0.019
  11. Burton JH, Garrett-Mayer E, Thamm DH. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma. Vet Comp Oncol. 2013 Dec; 11(4):306-15.
    View in: PubMed
    Score: 0.018
  12. Burton JH, Mitchell L, Thamm DH, Dow SW, Biller BJ. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. J Vet Intern Med. 2011 Jul-Aug; 25(4):920-6.
    View in: PubMed
    Score: 0.017
  13. Rebhun RB, Cruz SM, York D, Mazcko CN, Razmara AM, Patkar S, Judge SJ, Sholevar CJ, Shah RK, Zamora AE, Al-Nadaf S, Vail DM, Fan TM, Burton JH, Luker ME, Skorupski KA, Lejeune AT, Woolard K, Stewart SL, Sparger EE, Young J, Cohen-Davidyan T, Huang E, Beck JA, Murphy WJ, Kent MS, Culp WTN, LeBlanc AK, Canter RJ. Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma. Front Immunol. 2025; 16:1672790.
    View in: PubMed
    Score: 0.012
  14. Mason NJ, Selmic L, Ruple A, London CA, Barber L, Weishaar K, Perry JA, Mahoney J, Flesner B, Bryan JN, Willcox JL, Burton JH, Vail DM, Kisseberth WC, Balkman CE, McCleary-Wheeler AL, Curran KM, Leeper H, Woods JP, Mutsaers AJ, Higginbotham ML, Wouda RM, Wilson-Robles H, Dervisis N, Saba C, MacDonald-Dickinson VS, Hess PR, Cherukuri A, Rotolo A, Beck JA, Patkar S, Mazcko C, LeBlanc AK. Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2. Mol Ther. 2025 04 02; 33(4):1674-1686.
    View in: PubMed
    Score: 0.011
  15. Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma. J Vet Intern Med. 2024 Jul-Aug; 38(4):2282-2292.
    View in: PubMed
    Score: 0.011
  16. Burge R, Woolard KD, Willcox JL, Rebhun RB, Burton JH, Al-Nadaf S, Skorupski KA. High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy. J Am Anim Hosp Assoc. 2023 Jul 01; 59(4):167-176.
    View in: PubMed
    Score: 0.010
  17. Noall L, Lee S, Burton JH, Marquardt TM, Cermak J, Thombs LA, Rogic AM, Bryan JN, Chu S. A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma. Vet Comp Oncol. 2023 Sep; 21(3):509-519.
    View in: PubMed
    Score: 0.010
  18. Yang NS, Johnson EG, Palm CA, Burton JH, Rebhun RB, Kent MS, Culp WTN. MRI characteristics of canine prostatic neoplasia. Vet Radiol Ultrasound. 2023 Jan; 64(1):105-112.
    View in: PubMed
    Score: 0.009
  19. Culp WTN, Johnson EG, Giuffrida MA, Rebhun RB, Cawthra JK, Schwanz HA, Burton JH, Kent MS. Evaluation of the use of a novel bioabsorbable polymer drug-eluting microsphere for transarterial embolization of hepatocellular neoplasia in dogs. PLoS One. 2022; 17(8):e0269941.
    View in: PubMed
    Score: 0.009
  20. Rebhun RB, York D, Cruz SM, Judge SJ, Razmara AM, Farley LE, Brady RV, Johnson EG, Burton JH, Willcox J, Wittenburg LA, Woolard K, Dunai C, Stewart SL, Sparger EE, Withers SS, Gingrich AA, Skorupski KA, Al-Nadaf S, LeJeune AT, Culp WT, Murphy WJ, Kent MS, Canter RJ. Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response. J Immunother Cancer. 2022 06; 10(6).
    View in: PubMed
    Score: 0.009
  21. Brady RV, Rebhun RB, Skorupski KA, Burton JH, Al-Nadaf S, Choi E, Willcox JL. Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs. J Vet Diagn Invest. 2022 May; 34(3):465-473.
    View in: PubMed
    Score: 0.009
  22. Culp WTN, Johnson EG, Giuffrida MA, Palm CA, Skorupski KA, Burton JH, Rebhun RB, Willcox JL, Kent MS, Rodriguez CO, Glaiberman CB. Procedural description and prospective evaluation of short-term outcome for the use of prostatic artery embolization in dogs with carcinoma of the prostate. J Am Vet Med Assoc. 2021 11 15; 259(10):1154-1162.
    View in: PubMed
    Score: 0.009
  23. Culp WTN, Johnson EG, Palm CA, Burton JH, Rebhun RB, Rodriguez CO, Kent MS, Glaiberman CB. Use of percutaneous microwave ablation in the treatment of retroperitoneal neoplasia in three dogs. J Am Vet Med Assoc. 2021 11 15; 259(10):1171-1177.
    View in: PubMed
    Score: 0.009
  24. LeBlanc AK, Mazcko CN, Cherukuri A, Berger EP, Kisseberth WC, Brown ME, Lana SE, Weishaar K, Flesner BK, Bryan JN, Vail DM, Burton JH, Willcox JL, Mutsaers AJ, Woods JP, Northrup NC, Saba C, Curran KM, Leeper H, Wilson-Robles H, Wustefeld-Janssens BG, Lindley S, Smith AN, Dervisis N, Klahn S, Higginbotham ML, Wouda RM, Krick E, Mahoney JA, London CA, Barber LG, Balkman CE, McCleary-Wheeler AL, Suter SE, Martin O, Borgatti A, Burgess K, Childress MO, Fidel JL, Allstadt SD, Gustafson DL, Selmic LE, Khanna C, Fan TM. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs. Clin Cancer Res. 2021 06 01; 27(11):3005-3016.
    View in: PubMed
    Score: 0.009
  25. LeBlanc AK, Atherton M, Bentley RT, Boudreau CE, Burton JH, Curran KM, Dow S, Giuffrida MA, Kellihan HB, Mason NJ, Oblak M, Selmic LE, Selting KA, Singh A, Tjostheim S, Vail DM, Weishaar KM, Berger EP, Rossmeisl JH, Mazcko C. Veterinary Cooperative Oncology Group-Common Terminology Criteria for Adverse Events (VCOG-CTCAE v2) following investigational therapy in dogs and cats. Vet Comp Oncol. 2021 Jun; 19(2):311-352.
    View in: PubMed
    Score: 0.008
  26. Willcox JL, Spriet M, Zwingenberger AL, Phillips KL, Burton JH, Skorupski KA, Hansen KS, Affolter VK, Woolard KD, Beylin D, Giuffrida MA. Evaluation of accuracy for 18 F-FDG positron emission tomography and computed tomography for detection of lymph node metastasis in canine oral malignant melanoma. Vet Comp Oncol. 2021 Sep; 19(3):463-472.
    View in: PubMed
    Score: 0.008
  27. Griffin MA, Culp WTN, Giuffrida MA, Ellis P, Tuohy J, Perry JA, Gedney A, Lux CN, Milovancev M, Wallace ML, Hash J, Mathews K, Liptak JM, Selmic LE, Singh A, Palm CA, Balsa IM, Mayhew PD, Steffey MA, Rebhun RB, Burton JH, Kent MS. Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases. J Vet Intern Med. 2020 Jan; 34(1):274-282.
    View in: PubMed
    Score: 0.008
  28. Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB. Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma. Vet Comp Oncol. 2019 Sep; 17(3):242-252.
    View in: PubMed
    Score: 0.007
  29. Withers SS, York D, Johnson E, Al-Nadaf S, Skorupski KA, Rodriguez CO, Burton JH, Guerrero T, Sein K, Wittenburg L, Rebhun RB. In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers. Vet Comp Oncol. 2018 Dec; 16(4):571-579.
    View in: PubMed
    Score: 0.007
  30. Halsey CHC, Thamm DH, Weishaar KM, Burton JH, Charles JB, Gustafson DL, Avery AC, Ehrhart EJ. Expression of Phosphorylated KIT in Canine Mast Cell Tumor. Vet Pathol. 2017 05; 54(3):387-394.
    View in: PubMed
    Score: 0.006
  31. Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
    View in: PubMed
    Score: 0.006
  32. Saba C, Paoloni M, Mazcko C, Kisseberth W, Burton JH, Smith A, Wilson-Robles H, Allstadt S, Vail D, Henry C, Lana S, Ehrhart EJ, Charles B, Kent M, Lawrence J, Burgess K, Borgatti A, Suter S, Woods P, Gordon I, Vrignaud P, Khanna C, LeBlanc AK. A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model. PLoS One. 2016; 11(2):e0149194.
    View in: PubMed
    Score: 0.006
  33. Kim SH, Burton J, Yu CR, Sun L, He C, Wang H, Morse HC, Egwuagu CE. Dual Function of the IRF8 Transcription Factor in Autoimmune Uveitis: Loss of IRF8 in T Cells Exacerbates Uveitis, Whereas Irf8 Deletion in the Retina Confers Protection. J Immunol. 2015 Aug 15; 195(4):1480-8.
    View in: PubMed
    Score: 0.006
  34. Selmic LE, Burton JH, Thamm DH, Withrow SJ, Lana SE. Comparison of carboplatin and doxorubicin-based chemotherapy protocols in 470 dogs after amputation for treatment of appendicular osteosarcoma. J Vet Intern Med. 2014 Mar-Apr; 28(2):554-63.
    View in: PubMed
    Score: 0.005
  35. Biller BJ, Guth A, Burton JH, Dow SW. Decreased ratio of CD8+ T cells to regulatory T cells associated with decreased survival in dogs with osteosarcoma. J Vet Intern Med. 2010 Sep-Oct; 24(5):1118-23.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)